GlobeNewswire

Cisco and Portugal's Government Announce Collaboration to Accelerate Country Digitization

Dela

Collaboration focuses on innovative tech start-ups, digital infrastructures, digital skills, and cybersecurity

 

LISBON, Portugal, March 02, 2018 (GLOBE NEWSWIRE) -- The Government of Portugal and Cisco signed a memorandum of understanding (MoU) to accelerate country digitization. The signing followed a meeting yesterday between Portugal's Prime Minister António Costa, Cisco Chairman and Chief Executive Officer Chuck Robbins, and Sofia Tenreiro, General Manager of Cisco Portugal.

Over the next two years, Portugal and Cisco will cooperate to capture opportunities presented by a digital economy, with the aim to positively impact economic growth, education, innovation, and competitiveness as well as social inclusion and quality of life.

The MoU will focus on several key points that are part of Portugal's National Reforms Program. These include support for entrepreneurship and business innovation, with a specific focus on start-ups; increasing and improving digital skills; the application of innovative digital technologies across public sector services, education, Industry 4.0, mobility; and cybersecurity.

Key highlights

  • Entrepreneurship and digital innovation: Supporting tech start-ups is one of the main pillars of the government's digital strategy. Cisco will continue the collaboration with Startup Portugal in priority areas such as security, mobility, and Internet of Things. Cisco also intends to evaluate support for other start-up programs and provide local start-ups with access to its European Venture Capital initiative and Incubation program to help them accelerate their business and expand internationally.
     
  • Digital skills and smart education: Cisco will use its proven Cisco® Networking Academy® (NetAcad) program to provide training for digital skills, with courses focused on next-generation networks and cybersecurity. Cisco and the Ministry of Education will evaluate the use of NetAcad content in secondary schools, and there is an objective to reach other organizations and people above the age of 45. The goal is to increase the annual number of students from around 3,000 currently to 7,000 by 2020. Furthermore, Cisco intends to help the Ministry design smart campuses and the digital school of the future to optimize study environments.
     
  • Connected government and public services: digital transformation of the Public sector is a priority for Portugal's government. The partnership includes working with several ministries, with a focus on public administration modernization, health, justice, and defense.  The aim is to create highly secure platforms that will help enable extensive government collaboration and digital services, thus increasing efficiency and flexibility and reducing costs.
     
  • Industry 4.0 and mobility: Portugal's government launched a four-year Industry 4.0 plan to capture the benefits of digitization in strategic sectors. Cisco will support this plan by focusing on tourism, transportation, cities, and regions. The goal of this pillar is to improve services to citizens, visitors, and businesses, as well as to help competitiveness and operational efficiency. Cisco also intends to work with Turismo de Portugal to take advantage of Wi-Fi with analytics to improve experience and services and attract more visitors to the historical centers in Portugal. Cooperation in specific EU programs such as WiFi4EU to improve public wireless services is also planned.
     
  • Cybersecurity and digital infrastructures: Securing critical infrastructures, information systems, and online services against cyberthreats is a government priority. Cisco intends to collaborate with ministries and other entities such as Gabinete Nacional de Segurança to help ensure safety and privacy in critical national infrastructures. Cisco will help to design and consolidate national digital infrastructures as the platform for driving innovation, automation, and security across ministries.

Supporting Quotes

  • António Costa, Prime Minister of Portugal" By accelerating the national digitization agenda, Portugal can increase GDP growth, create jobs, and improve digital inclusion for our people and businesses. We strongly welcome Cisco's contribution to  create a sustainable innovation ecosystem that will enable our country to better compete in the global digital economy. "
  • Chuck Robbins, Chairman and CEO, Cisco:  " Cisco is proud to partner with Portugal's government, businesses, and citizens in their commitment to digitize the nation and become a European leader in digital transformation. We are committed to helping accelerate the Portuguese ecosystem of talent, entrepreneurship, and innovation that is key to creating a digital Portugal, and can bring even greater value to the country."
     
  • Sofia Tenreiro,  General Manager, Cisco Portugal:  " Cisco Portugal values the opportunity this agreement represents and is fully committed to work with the innovation ecosystem, including public and private organizations, schools, and academia, to accelerate  the national digitization efforts . Our goals are long term, and we want to play a significant role in the growth and competitiveness of the country."

Supporting Resources

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco, the Cisco logo, and Networking Academy are registered trademarks or trademarks of Cisco Systems, Inc. and/or its affiliates in the United States and certain other countries. All other trademarks mentioned in this document are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. This document is Cisco Public Information.

http://newsroom.cisco.com/rss-feeds

Ariadna Hernández
ariahern@cisco.com

A photo accompanying this announcement is available at http://www.globenewswire.com/NewsRoom/AttachmentNg/642c89e8-cdac-42a0-9095-857635f2f227




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Arcoma AB: Investerarmöten våren 201915.2.2019 08:46:00Pressmeddelande

15 februari 2019 PRESSRELEASE Arcoma har som ambition att fortsätta öka sitt aktieägarfokus och kontinuerligt förbättra kommunikationen med aktieägare. Under våren 2019 kommer Arcoma medverka på flertalet investerarmöten där aktuella händelser och aktiviteter presenteras. Här ges en ökad inblick i bolagets vision och strategier samt en möjlighet till att ställa frågor till bolagets ledning. SvD Börsplus Temadag "Dubblare" Dag, tid och plats: 5 mars, kl. 13.00, GT 30, Grev Turegatan 30, Stockholm Stockholm Corporate Finance Life Science event Dag, tid och plats: 14 mars, kl. 07.30, Berns, Kammarsalen, Stockholm Redeyes Medtech & Diagnostics event Dag, tid och plats: 14:e maj, Redeye, Mäster Samuelsgatan 42, Stockholm För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soderqvist at arcoma.se Om Arcoma Arcoma, med lång erfarenhet av branschen, är en ledande leverantör av integrerade digitala röntgensystem med hög kvalite

Corline Biomedical AB: Första patient doserad med Renaparin®15.2.2019 08:42:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man inkluderat första patienten i fas 1-studien RENAPAIR 01. Patienten inkluderades vid transplantationsavdelningen på Uppsala Akademiska sjukhus. Renaparin® är en produkt under utveckling för att förbättra njurtransplantation. I Corlines studie RENAPAIR 01 utvärderas produkten med avseende på tolerabilitet och säkerhet. Studien öppnades för patientrekrytering i slutet av 2018 och första patient är nu doserad och inkluderad i studien. Totalt skall 18 patienter rekryteras och när de 4 första patienterna är utvärderade i Uppsala, öppnas också Karolinska Universitetssjukhuset i Huddinge för rekrytering till studien. Henrik Nittmar, VD i Corline Biomedical AB, kommenterar "Det händer mycket i Corline för tillfället och alla arbetar hårt för att målbilden i bolaget skall uppfyllas. Det gäller såväl vår interna organisation som våra externa samarbetspartners. Därför är det extra roligt när vi når avgörande milstolpar i utvec

Corline Biomedical AB: Rekryterar Lars Olsson som Head of CMC14.2.2019 12:44:00Pressmeddelande

Corline Biomedical AB ("Corline" eller "Bolaget") meddelar idag att man rekryterat Lars Olsson till den nyinrättade tjänsten som Head of CMC (Chemistry, Manufacturing & Control). Lars Olsson hade tidigare samma tjänst hos Wilson Therapeutics AB, som under 2018 förvärvades av amerikanska Alexion. Lars Olsson kommer att ansvara för Corlines samtliga aktiviteter inom tillverkning och kontroll relaterat till bolagets läkemedelsprodukter, med särskilt fokus på Renaparin® inför kommande fas 2- och fas 3-utveckling. I slutet av 2018 meddelade Corline att patientrekryteringen startar i bolagets fas 1-studie RENAPAIR 01, där produkten Renaparin®, som är under utveckling för att förbättra utfallet av njurtransplantation, utvärderas med avseende på tolerabilitet och säkerhet. Därmed tog en ny utvecklingsfas vid i bolaget i vilken alltmer resurser fokuseras på att förbereda den fortsatta kliniska utvecklingen av produkten genom fas 2 och fas 3 i syfte att slutligen kunna registrera produkten för k

Arcoma AB: Canon och Arcoma tecknar distributörsavtal för Turkiet14.2.2019 10:38:00Pressmeddelande

14 februari 2019 Canon Medical Systems i Turkiet och Arcoma har tecknat ett distributörsavtal som gör att Canon kommer att kunna sälja Arcomas produkter i Turkiet från och med den 15 februari 2019. Canon är sedan tidigare återförsäljare för Arcomas produkter i Nordamerika och utvalda länder i Europa. Detta samarbete utökas nu till Turkiet som är det första land i Canons Asien organisation att välja Arcoma som en formell partner. "Att vi stärker och formaliserar samarbetet med Canon även i Turkiet är ännu ett erkännande av Arcoma som leverantör av högkvalitativa röntgensystem. Canon i Turkiet förbereder ett flertal större upphandlingar till sjukhus där Arcomas lösningar ingår. Avtal som detta ingår i Arcomas strategi att utöka med nya försäljningskanaler och att expandera till nya länder för att skapa framtida tillväxt." kommenterar Arcomas VD, Jesper Söderqvist. För ytterligare information, vänligen kontakta: Arcomas VD Jesper Söderqvist, Telefon: +46 470 70 69 81, E-mail: jesper.soder

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

Karolinska Development's portfolio company OssDsign raises SEK 64m and aims for listing on Nasdaq First North12.2.2019 09:00:00Pressmeddelande

STOCKHOLM, February 12, 2019. Karolinska Development's portfolio company OssDsign announces today the closing of a private placement of SEK 64 million. Swedish private investors and the French investment management company Alto Invest have taken part in the private placement. OssDsign will now begin the process towards a listing on Nasdaq First North in 2019. The proceeds from the private placement will be used for continued sales expansion in Europe and the US of OssDsign regenerative implant solutions for improved healing of bone defects. Moreover, funds will be used for entering new markets, primarily preparing for market introduction in Japan where the company in parallel to the regulatory process will initiate pre marketing activities. With ethical committee approval already in place, leading surgeons in Japan can start building experience with the OssDsign technology prior to regulatory approval and launch. OssDsign prepares for a listing on Nasdaq Stockholm First North in 2019.

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum